Skin Tumors

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 56

DR.

ATA UR REHMAN
REGISTRAR,
DEPT. OF GENERAL SURGERY,
DR. ZIAUDDIN HOSPITAL,
KDLB CAMPUS.
SKIN:
 The skin is the largest organ of the body.

 Skin weighs about 6 pounds.

 Total area of about 20 square feet.

 Varies in thickness from site to site being


thickest on palm and soles.
ANATOMY:
 EPIDERMIS
 Stratum basale
 Stratum spinosum
 Stratum granulosum
 Stratum lucidum
 Stratum corneum

 DERMIS
 Paillary layer
 Reticular layer
FUNCTIONS:

 Barrier to the environment.

 Temperature and water homeostasis.

 Excretion

 Endocrine and metabolic function.

 Sensory organ for pain and pressure.


CONGINITAL/GENETIC SKIN
LESIONS:
 NEUROFIBROMATOSIS:

 Arise from Schwann cells.


 Two different type.
 70% type 1. ( autosomal dominant)
 Chromosome 17 mutation.
NEUROFIBROMATOSIS:
NEUROFIBROMATOSIS:
XERODERMA PIGMENTOSA:
 Autosomal recessive ( chromosome 9).

 Intolerance to Ultra-Voilet radiations.

 Erythema, pigmentation, photophobia.

 Mostly expire in early adulthood.


XERODERMA PIGMENTOSA:
XERODERMA PIGMENTOSA:
INFLAMATORY CONDITIONS:

 Hidradenitis Suppurativa:

 Chronic inflammatory disease.


 Involves apocrine glands of axilla or groin.
 Common in females (4X).
 Follicular occlusion------ folliculitis----- sec. infection.
 TREATMENT:
 Maintain hygiene.
 Topical / oral antibiotics.
 Anti-androgens.
 Surgical excision.
Hidradenitis Suppurativa
INFECTIONS:
 IMPETIGO:
 Superficial skin lesion. (staph and strepococcus)
 Blisture ---- rupture ----- honey colored crust.
 Washing, local and systemic antibiotics.

 CELLULITIS:
 Bacterial infection of skin and subcutaneous tissue.
 Erythematous, edematous, painful.
 Fever and raised TLC
 Broad spectrum antibiotic, limb elevation
IMPETIGO
IMPETIGO
CELLULITIS
CELLULITIS
 NECROTISING FASCIITIS:

 Polymicrobial synergistic infection involving deep


layers.

 80% have history of trauma or infection.

 Rapidly progress to septic shock

 Resuscitation, antibiotics, surgical debridement.


NECROTIZING FACITIS
EPIDERMAL CYST:
 Cysts lined by stratified squamous epithelium.
 Commonly known as sebaceous cyst.
 Hairy areas of the body.
 Fixed to skin, have a punctum.
 Treatment:
 Not inflamed ----- excision
 Inflamed ----- antibiotics then incision and drainage.
EPIDERMOID CYST
SKIN TUMOURS

BENIGN MALIGNANT
BENIGN LESIONS:
BASAL CELL PAPILLOMA:
(SEBORRHEOEIC
KERATOSIS)
BASAL CELL PAPILLOMA:
(SEBORRHEOEIC
KERATOSIS)
BENIGN LESIONS:
 BASAL CELL PAPILLOMA
(SEBORRHEOEIC KERATOSIS)

 Soft, pigmented and hyperkeratotic.


 Arise from basal layer of epidermis
 Contains melaonocytes.
 Most common benign skin tumour of old age.
BENIGN LESIONS:

CUTANEOUS PAPILLOMA
CUTANEOUS PAPILLOMA:
 Skin tag, cutaneous papilloma, soft fibroma

 Common, benign, flesh-colored papule

 Uncommon before age 30, very common


thereafter

 Found in 25% of adults, increase with age

 F>m, obesity, diabetes, pregnancy, intesinal


polyposis syndromes
http://www.visualdxhealth.com/adult/acrochordonSkinTag.htm
BENIGN LESIONS:
 MOLES/NAEVI:

 Migrated melanocyets from neural crest to


epidermis during embryogenesis.

 Epidermis----- mole

 Dermis ----- naevi


Syringomas  Sweat duct tumors

 More common in
females

 May first appear in


adolescence, but more
often in the third decade

 Found around eyelids


and are skin colored to
yellow in appearance
PREMALIGNANT LESIONS:

 SOLAR KERATOSIS:

 Area of dyskeratosis and cellular atypia.

 20% can transform into squamous cell carcinoma.


SOLAR KERATOSIS
PREMALIGNANT LESIONS:

 CUTEANOUS HORN:

 Excessive Keratin deposition.

 10% have underlying squamous call carcinama.


CUTEANOUS HORN
PREMALIGNANT LESIONS:
 KERATOACANTHOMA:
PREMALIGNANT LESIONS:
 KERATOACANTHOMA:
PREMALIGNANT LESIONS:

 KERATOACANTHOMA:

 Symmetrical cutaneous growth with central


keratin plug.
 Twice common in men
 Common site face
 50 to 70 yrs
 Excision is recommended.
PREMALIGNANT LESIONS:
 Bowen’s disease:

 Carcinoma in situ
 3-11% progress to SCC.
 Chemical irritant, solar radiation, HPaV.
 Surgical excision.
BOWEN’S DISEASE
BOWEN’S DISEASE
MALIGNANT LESION:
 BASAL CELL CARCINOMA:
 Slowly growing
 Locally invasive
 Arise from basal epidermis and hair follicles.
 Predisposing factor ---- UV radiations
 33% in body parts not exposed.
 Middle age or elderly
 90 % upper face.
 White colored people
 Common in men.
 Rarely metastasise.
 BASAL CELL CARCINOMA:

 > 2 cm are high risk.


 Treatment:
 Surgical excision with margins of 1.5 cm
 Mohs’ micrographic surgery.
BASAL CELL CARCINOMA
BASAL CELL CARCINOMA
MALIGNANT LESION:
 SQUAMOUS CELL CARCINOMA:
 Malignant tumor of keratinising cells.
 Arise from stratum germinosum.
 Second most common skin tumor. (4X less than BCC)
 Twice common in men, white skinned and smokers.
 Associated with chronic inflamation, sinus tracts,
burns.
 Metastasize.
 Treatment:
 Surgical excision ----- if < 2 cm ----clearance 4mm
if > 2 cm ----clearance 1cm.
SQUAMOUS CELL CARCINOMA
SQUAMOUS CELL CARCINOMA
MALIGNANT LESION:
 MALIGNANT MAELONOMA:

 Cancer of melanin producing cells.


 Largely by exposure to UV radiations.
 < 5% of all skin malagnacies
 Most common cancer of young age
 Most likely cause of cancer related deaths.
 Treatment:
 Surgical excision
MALIGNANT MAELONOMA
MALIGNANT MAELONOMA
QUESTIONS??

You might also like